[L02BA01, tamoxifen, The serum concentration of Afatinib can be increased when it is combined with Tamoxifen.]
[L01CB02, teniposide, Afatinib may decrease the excretion rate of Teniposide which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be increased when it is combined with Afatinib.]
[G03BA03, testosterone, Afatinib may decrease the excretion rate of Testosterone which could result in a higher serum level.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Tetracaine.]
[V04CJ01, thyrotropin, The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Afatinib.]
[V04CJ02, thyrotropin-releasing hormone, The therapeutic efficacy of Protirelin can be decreased when used in combination with Afatinib.]
[N06AX05, trazodone, The serum concentration of Afatinib can be decreased when it is combined with Trazodone.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be increased when it is combined with Afatinib.]
[L01EX04, vandetanib, The serum concentration of Afatinib can be increased when it is combined with Vandetanib.]
[A10BH05, linagliptin, The serum concentration of Afatinib can be increased when it is combined with Linagliptin.]
[J05AP02, telaprevir, The serum concentration of Afatinib can be increased when it is combined with Telaprevir.]
[J05AG05, rilpivirine, Rilpivirine may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[B01AF01, rivaroxaban, Afatinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, The serum concentration of Indacaterol can be increased when it is combined with Afatinib.]
[B01AC24, ticagrelor, The serum concentration of Afatinib can be increased when it is combined with Ticagrelor.]
[C08DA01, verapamil, The serum concentration of Afatinib can be increased when it is combined with Verapamil.]
[L01CA01, vinblastine, The serum concentration of Vinblastine can be increased when it is combined with Afatinib.]
[L01CA02, vincristine, The excretion of Vincristine can be decreased when combined with Afatinib.]
[J05AF01, zidovudine, Afatinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L01EC01, vemurafenib, The serum concentration of Afatinib can be increased when it is combined with Vemurafenib.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be increased when it is combined with Afatinib.]
[L01ED01, crizotinib, The serum concentration of Afatinib can be increased when it is combined with Crizotinib.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[J02AC03, voriconazole, The serum concentration of Afatinib can be increased when it is combined with Voriconazole.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[L01EK01, axitinib, The serum concentration of Axitinib can be increased when it is combined with Afatinib.]
[R07AX02, ivacaftor, The serum concentration of Afatinib can be increased when it is combined with Ivacaftor.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Afatinib.]
[L01BC05, gemcitabine, The serum concentration of Gemcitabine can be increased when it is combined with Afatinib.]
[G04BE10, avanafil, Avanafil may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[G04BD12, mirabegron, The serum concentration of Afatinib can be increased when it is combined with Mirabegron.]
[L01XG02, carfilzomib, The serum concentration of Afatinib can be increased when it is combined with Carfilzomib.]
[V03AX03, cobicistat, The serum concentration of Afatinib can be increased when it is combined with Cobicistat.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be increased when it is combined with Afatinib.]
[L04AA31, teriflunomide, Teriflunomide may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[L01EX05, regorafenib, The serum concentration of Afatinib can be increased when it is combined with Regorafenib.]
[J05AE04, nelfinavir, Nelfinavir may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Afatinib.]
[N06DA02, donepezil, Afatinib may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[G04BE03, sildenafil, The serum concentration of Afatinib can be increased when it is combined with Sildenafil.]
[L01EA05, ponatinib, The serum concentration of Afatinib can be increased when it is combined with Ponatinib.]
[B01AF02, apixaban, Afatinib may decrease the excretion rate of Apixaban which could result in a higher serum level.]
[C10AX12, lomitapide, The serum concentration of Afatinib can be increased when it is combined with Lomitapide.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be increased when it is combined with Afatinib.]
[A10BK02, canagliflozin, The serum concentration of Afatinib can be increased when it is combined with Canagliflozin.]
[A06AX06, tegaserod, Afatinib may decrease the excretion rate of Tegaserod which could result in a higher serum level.]
[H03AA04, tiratricol, The therapeutic efficacy of Tiratricol can be decreased when used in combination with Afatinib.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Benzocaine.]
[M01AH01, celecoxib, Afatinib may decrease the excretion rate of Celecoxib which could result in a higher serum level.]
[L04AA18, everolimus, The serum concentration of Afatinib can be increased when it is combined with Everolimus.]
[L01EC02, dabrafenib, The serum concentration of Dabrafenib can be increased when it is combined with Afatinib.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Benzyl alcohol.]
[H05AA03, parathyroid hormone, The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Afatinib.]
[S01AA13, fusidic acid, Fusidic acid may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[J05AJ03, dolutegravir, Afatinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.]
[C02KX05, riociguat, Afatinib may decrease the excretion rate of Riociguat which could result in a higher serum level.]
[J05AP05, simeprevir, The serum concentration of Afatinib can be increased when it is combined with Simeprevir.]
[J05AP08, sofosbuvir, Afatinib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[L01ED02, ceritinib, The serum concentration of Ceritinib can be increased when it is combined with Afatinib.]
[B01AC26, vorapaxar, The serum concentration of Afatinib can be increased when it is combined with Vorapaxar.]
[L01XH04, belinostat, The serum concentration of Belinostat can be increased when it is combined with Afatinib.]
[L01EM01, idelalisib, Afatinib may decrease the excretion rate of Idelalisib which could result in a higher serum level.]
[N07XX08, tafamidis, The serum concentration of Afatinib can be increased when it is combined with Tafamidis.]
[N05CM19, suvorexant, The serum concentration of Afatinib can be increased when it is combined with Suvorexant.]
[A16AX10, eliglustat, The serum concentration of Afatinib can be increased when it is combined with Eliglustat.]
[A06AH03, naloxegol, The serum concentration of Naloxegol can be increased when it is combined with Afatinib.]
[L01EX09, nintedanib, The serum concentration of Nintedanib can be increased when it is combined with Afatinib.]
[J05AP09, dasabuvir, Dasabuvir may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[B01AF03, edoxaban, The serum concentration of Edoxaban can be increased when it is combined with Afatinib.]
[L01EF01, palbociclib, The serum concentration of Afatinib can be increased when it is combined with Palbociclib.]
[L01EX08, lenvatinib, Afatinib may decrease the excretion rate of Lenvatinib which could result in a higher serum level.]
[L01XH03, panobinostat, The serum concentration of Panobinostat can be increased when it is combined with Afatinib.]
[J05AP07, daclatasvir, The serum concentration of Afatinib can be increased when it is combined with Daclatasvir.]
[N02BE01, acetaminophen, The serum concentration of Acetaminophen can be increased when it is combined with Afatinib.]
[J05AP06, asunaprevir, The serum concentration of Afatinib can be increased when it is combined with Asunaprevir.]
[A04AD14, rolapitant, The serum concentration of Afatinib can be increased when it is combined with Rolapitant.]
[G02CX02, flibanserin, The serum concentration of Afatinib can be increased when it is combined with Flibanserin.]
[A02BC03, lansoprazole, Lansoprazole may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[J02AC05, isavuconazole, The serum concentration of Afatinib can be increased when it is combined with Isavuconazole.]
[L01EB04, osimertinib, The serum concentration of Osimertinib can be increased when it is combined with Afatinib.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Afatinib.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be increased when it is combined with Afatinib.]
[L01ED03, alectinib, Alectinib may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[B01AC27, selexipag, The serum concentration of Selexipag can be increased when it is combined with Afatinib.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[L01XX52, venetoclax, The serum concentration of Afatinib can be increased when it is combined with Venetoclax.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Bupivacaine.]
[N07BC01, buprenorphine, Buprenorphine may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[L01XX27, arsenic trioxide, The serum concentration of Afatinib can be increased when it is combined with Arsenic trioxide.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[L01XK03, rucaparib, Afatinib may decrease the excretion rate of Rucaparib which could result in a higher serum level.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Oxybuprocaine.]
[J05AE09, tipranavir, The serum concentration of Afatinib can be increased when it is combined with Tipranavir.]
[H03BA03, benzylthiouracil, The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Afatinib.]
[H05AA04, abaloparatide, The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Afatinib.]
[L01ED04, brigatinib, Afatinib may decrease the excretion rate of Brigatinib which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[J01MA23, delafloxacin, Afatinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[B01AF04, betrixaban, The serum concentration of Betrixaban can be increased when it is combined with Afatinib.]
[L01XX59, enasidenib, The serum concentration of Afatinib can be increased when it is combined with Enasidenib.]
[L01EH02, neratinib, The serum concentration of Afatinib can be increased when it is combined with Neratinib.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Afatinib.]
[L01EM02, copanlisib, The serum concentration of Copanlisib can be increased when it is combined with Afatinib.]
[L01EF03, abemaciclib, The serum concentration of Abemaciclib can be increased when it is combined with Afatinib.]
[C07AB07, bisoprolol, The serum concentration of Bisoprolol can be increased when it is combined with Afatinib.]
[J05AX18, letermovir, Letermovir may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[C01AA02, acetyldigoxins, Afatinib may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Capsaicin.]
[A10BK04, ertugliflozin, Afatinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.]
[L02BB05, apalutamide, The serum concentration of Afatinib can be decreased when it is combined with Apalutamide.]
[H03BB01, carbimazole, The therapeutic efficacy of Carbimazole can be decreased when used in combination with Afatinib.]
[C07AG02, carvedilol, The serum concentration of Afatinib can be increased when it is combined with Carvedilol.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[N03AX24, cannabidiol, Cannabidiol may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[B02BX08, avatrombopag, Avatrombopag may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be increased when it is combined with Afatinib.]
[H01CC03, elagolix, The serum concentration of Afatinib can be increased when it is combined with Elagolix.]
[N03AX17, stiripentol, The excretion of Afatinib can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, Afatinib may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.]
[L01EM04, duvelisib, Afatinib may decrease the excretion rate of Duvelisib which could result in a higher serum level.]
[L01EB07, dacomitinib, The serum concentration of Afatinib can be increased when it is combined with Dacomitinib.]
[J01AA14, sarecycline, The serum concentration of Afatinib can be increased when it is combined with Sarecycline.]
[J01AA15, omadacycline, The serum concentration of Omadacycline can be increased when it is combined with Afatinib.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Chloroprocaine.]
[L01XK04, talazoparib, The serum concentration of Talazoparib can be increased when it is combined with Afatinib.]
[R03BB08, revefenacin, Afatinib may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L01ED05, lorlatinib, The serum concentration of Afatinib can be decreased when it is combined with Lorlatinib.]
[L01EX12, larotrectinib, The serum concentration of Larotrectinib can be increased when it is combined with Afatinib.]
[L01EX13, gilteritinib, Gilteritinib may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[L01XJ03, glasdegib, The serum concentration of Afatinib can be increased when it is combined with Glasdegib.]
[A06AX05, prucalopride, The serum concentration of Prucalopride can be increased when it is combined with Afatinib.]
[J01FA09, clarithromycin, The serum concentration of Afatinib can be increased when it is combined with Clarithromycin.]
[L01EN01, erdafitinib, The serum concentration of Afatinib can be increased when it is combined with Erdafitinib.]
[N05BA09, clobazam, The serum concentration of Clobazam can be increased when it is combined with Afatinib.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be increased when it is combined with Afatinib.]
[L02BB06, darolutamide, The serum concentration of Afatinib can be increased when it is combined with Darolutamide.]
[L01EJ02, fedratinib, The serum concentration of Afatinib can be increased when it is combined with Fedratinib.]
[L01EX14, entrectinib, The serum concentration of Afatinib can be increased when it is combined with Entrectinib.]
[N07XX11, pitolisant, The serum concentration of Afatinib can be increased when it is combined with Pitolisant.]
[J01XX12, lefamulin, Afatinib may decrease the excretion rate of Lefamulin which could result in a higher serum level.]
[N04CX01, istradefylline, The serum concentration of Afatinib can be increased when it is combined with Istradefylline.]
[J01XX09, daptomycin, The serum concentration of Daptomycin can be increased when it is combined with Afatinib.]
[N02CC08, lasmiditan, The serum concentration of Afatinib can be increased when it is combined with Lasmiditan.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Afatinib.]
[L01FX13, enfortumab vedotin, The serum concentration of Enfortumab vedotin can be increased when it is combined with Afatinib.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be increased when it is combined with Afatinib.]
[L01XX72, tazemetostat, Afatinib may decrease the excretion rate of Tazemetostat which could result in a higher serum level.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Afatinib.]
[L04AA38, ozanimod, Afatinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.]
[L01EE04, selumetinib, Afatinib may decrease the excretion rate of Selumetinib which could result in a higher serum level.]
[C01BD07, dronedarone, The serum concentration of Afatinib can be increased when it is combined with Dronedarone.]
[L01EH03, tucatinib, Tucatinib may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[L01EX17, capmatinib, The serum concentration of Afatinib can be increased when it is combined with Capmatinib.]
[L01EX19, ripretinib, The serum concentration of Afatinib can be increased when it is combined with Ripretinib.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Dyclonine.]
[J05AX29, fostemsavir, Afatinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level.]
[L01FX15, belantamab mafodotin, The serum concentration of Belantamab mafodotin can be increased when it is combined with Afatinib.]
[L01EX23, pralsetinib, The serum concentration of Pralsetinib can be increased when it is combined with Afatinib.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Afatinib.]
[A16AX20, lonafarnib, The serum concentration of Afatinib can be increased when it is combined with Lonafarnib.]
[L02BX04, relugolix, The serum concentration of Relugolix can be increased when it is combined with Afatinib.]
[L04AD03, voclosporin, The serum concentration of Afatinib can be increased when it is combined with Voclosporin.]
[L01EX21, tepotinib, The serum concentration of Tepotinib can be increased when it is combined with Afatinib.]
[L01EX25, umbralisib, The serum concentration of Afatinib can be increased when it is combined with Umbralisib.]
[V03AF12, trilaciclib, Afatinib may decrease the excretion rate of Trilaciclib which could result in a higher serum level.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[G03GA06, follitropin beta, The therapeutic efficacy of Follitropin can be decreased when used in combination with Afatinib.]
[L01FX22, loncastuximab tesirine, The serum concentration of Loncastuximab tesirine can be increased when it is combined with Afatinib.]
[L01XX73, sotorasib, The serum concentration of Afatinib can be increased when it is combined with Sotorasib.]
[L04AA48, belumosudil, The serum concentration of Afatinib can be increased when it is combined with Belumosudil.]
[V09GA01, technetium Tc 99m sestamibi, The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Afatinib.]
[N06AX25, St. John's wort extract, The serum concentration of Afatinib can be decreased when it is combined with St. John's Wort.]
[L01EA06, asciminib, The serum concentration of Afatinib can be increased when it is combined with Asciminib.]
[J05AX10, maribavir, The serum concentration of Afatinib can be increased when it is combined with Maribavir.]
[D11AH08, abrocitinib, The serum concentration of Afatinib can be increased when it is combined with Abrocitinib.]
[J04BA01, clofazimine, The serum concentration of Afatinib can be increased when it is combined with Clofazimine.]
[B06AX04, mitapivat, The serum concentration of Afatinib can be increased when it is combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Afatinib can be increased when it is combined with Pacritinib.]
[G03GB02, clomiphene, The serum concentration of Clomifene can be increased when it is combined with Afatinib.]
[J02AC06, oteseconazole, The serum concentration of Afatinib can be increased when it is combined with Oteseconazole.]
[L01EN04, futibatinib, The serum concentration of Futibatinib can be increased when it is combined with Afatinib.]
[A10BK06, sotagliflozin, The serum concentration of Afatinib can be increased when it is combined with Sotagliflozin.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Cocaine.]
[M04AC01, colchicine, The serum concentration of Colchicine can be increased when it is combined with Afatinib.]
[L04AA13, leflunomide, Afatinib may decrease the excretion rate of Leflunomide which could result in a higher serum level.]
[J02AC02, itraconazole, The serum concentration of Afatinib can be increased when it is combined with Itraconazole.]
[L01EA01, imatinib, Imatinib may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[J02AC04, posaconazole, The serum concentration of Posaconazole can be increased when it is combined with Afatinib.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Afatinib.]
[J05AF07, tenofovir disoproxil, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Afatinib.]
[S01XA18, cyclosporine, The serum concentration of Afatinib can be increased when it is combined with Cyclosporine.]
[C10AA07, rosuvastatin, Afatinib may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[C03XA02, conivaptan, The serum concentration of Afatinib can be increased when it is combined with Conivaptan.]
[G04BE09, vardenafil, The serum concentration of Afatinib can be increased when it is combined with Vardenafil.]
[L01DA01, dactinomycin, The serum concentration of Dactinomycin can be increased when it is combined with Afatinib.]
[L01DB02, daunorubicin, Afatinib may decrease the excretion rate of Daunorubicin which could result in a higher serum level.]
[L01XA03, oxaliplatin, Afatinib may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.]
[S03BA01, dexamethasone, Dexamethasone may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[L01EB01, gefitinib, Gefitinib may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[H05AA02, teriparatide, The therapeutic efficacy of Teriparatide can be decreased when used in combination with Afatinib.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Cinchocaine.]
[L01DC04, ixabepilone, The serum concentration of Afatinib can be increased when it is combined with Ixabepilone.]
[L01EB02, erlotinib, Erlotinib may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be increased when it is combined with Afatinib.]
[C01AA05, digoxin, Afatinib may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C10AX09, ezetimibe, Afatinib may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[H03BC01, potassium perchlorate, The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Afatinib.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Pramocaine.]
[C05CA03, diosmin, The serum concentration of Afatinib can be increased when it is combined with Diosmin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Diphenhydramine.]
[S01XA23, sirolimus, The serum concentration of Sirolimus can be increased when it is combined with Afatinib.]
[S02AA12, rifamycin SV, The serum concentration of Afatinib can be increased when it is combined with Rifamycin.]
[D06AX11, rifaximin, The serum concentration of Rifaximin can be increased when it is combined with Afatinib.]
[N07XX02, riluzole, Afatinib may decrease the excretion rate of Riluzole which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Ropivacaine.]
[L01EX01, sunitinib, Sunitinib may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[C03XA01, tolvaptan, The serum concentration of Tolvaptan can be increased when it is combined with Afatinib.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be increased when it is combined with Afatinib.]
[C02KX02, ambrisentan, The serum concentration of Ambrisentan can be increased when it is combined with Afatinib.]
[C01EB18, ranolazine, The serum concentration of Ranolazine can be increased when it is combined with Afatinib.]
[H05BA01, salmon calcitonin, The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Afatinib.]
[L01DB01, doxorubicin, The serum concentration of Doxorubicin can be increased when it is combined with Afatinib.]
[C10AA01, simvastatin, The serum concentration of Afatinib can be increased when it is combined with Simvastatin.]
[N02CC01, sumatriptan, Afatinib may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[C07AB13, talinolol, The serum concentration of Talinolol can be increased when it is combined with Afatinib.]
[L02BA02, toremifene, The serum concentration of Afatinib can be increased when it is combined with Toremifene.]
[G03GA05, follitropin alfa, The therapeutic efficacy of Follitropin can be decreased when used in combination with Afatinib.]
[N06AX16, venlafaxine, Venlafaxine may increase the excretion rate of Afatinib which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AX15, zonisamide, The serum concentration of Afatinib can be increased when it is combined with Zonisamide.]
[S01AA17, erythromycin, The serum concentration of Afatinib can be increased when it is combined with Erythromycin.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Afatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Etidocaine.]
[L01CB01, etoposide, The serum concentration of Etoposide can be increased when it is combined with Afatinib.]
[L04AD02, tacrolimus, The serum concentration of Afatinib can be increased when it is combined with Tacrolimus.]
[C10AA03, pravastatin, Pravastatin may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[L01BB06, clofarabine, Afatinib may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA40, cladribine, Afatinib may decrease the excretion rate of Cladribine which could result in a higher serum level.]
[J02AC01, fluconazole, The serum concentration of Afatinib can be increased when it is combined with Fluconazole.]
[L01BC02, fluorouracil, Afatinib may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[V04CX02, folic acid, Afatinib may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[J05AE10, darunavir, The serum concentration of Darunavir can be increased when it is combined with Afatinib.]
[L01EA02, dasatinib, The serum concentration of Dasatinib can be increased when it is combined with Afatinib.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be increased when it is combined with Afatinib.]
[L01EH01, lapatinib, The serum concentration of Afatinib can be increased when it is combined with Lapatinib.]
[A10BB01, glyburide, Afatinib may decrease the excretion rate of Glyburide which could result in a higher serum level.]
[H01AB01, thyrotropin alfa, The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Afatinib.]
[L01EX02, sorafenib, The serum concentration of Afatinib can be increased when it is combined with Sorafenib.]
[L01CE02, irinotecan, Afatinib may decrease the excretion rate of Irinotecan which could result in a higher serum level.]
[M04AA01, allopurinol, Afatinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[N06AA02, imipramine, The serum concentration of Imipramine can be increased when it is combined with Afatinib.]
[L01CE01, topotecan, The serum concentration of Topotecan can be increased when it is combined with Afatinib.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Articaine.]
[A10BH01, sitagliptin, The serum concentration of Sitagliptin can be increased when it is combined with Afatinib.]
[C10AA06, cerivastatin, Afatinib may decrease the excretion rate of Cerivastatin which could result in a higher serum level.]
[P02CF01, ivermectin, Afatinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[J02AB02, ketoconazole, The serum concentration of Afatinib can be increased when it is combined with Ketoconazole.]
[H02CA04, levoketoconazole, The serum concentration of Afatinib can be increased when it is combined with Levoketoconazole.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Lidocaine.]
[A07DA03, loperamide, The excretion of Loperamide can be decreased when combined with Afatinib.]
[N05AH01, loxapine, The serum concentration of Afatinib can be increased when it is combined with Loxapine.]
[L01EG01, temsirolimus, The serum concentration of Afatinib can be increased when it is combined with Temsirolimus.]
[L01BA05, pralatrexate, Afatinib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The serum concentration of Afatinib can be increased when it is combined with Nilotinib.]
[V04CX04, mannitol, The serum concentration of Mannitol can be increased when it is combined with Afatinib.]
[C01AA08, medigoxin, Afatinib may decrease the excretion rate of Metildigoxin which could result in a higher serum level.]
[P01BC02, mefloquine, The serum concentration of Afatinib can be increased when it is combined with Mefloquine.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Mepivacaine.]
[N05AX13, paliperidone, The serum concentration of Afatinib can be increased when it is combined with Paliperidone.]
[J05AF05, lamivudine, Afatinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[H03BB02, methimazole, The therapeutic efficacy of Methimazole can be decreased when used in combination with Afatinib.]
[L04AX03, methotrexate, Afatinib may decrease the excretion rate of Methotrexate which could result in a higher serum level.]
[V04CG05, methylene blue, The serum concentration of Afatinib can be increased when it is combined with Methylene blue.]
[G03XB01, mifepristone, The serum concentration of Afatinib can be increased when it is combined with Mifepristone.]
[L01DB07, mitoxantrone, Afatinib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level.]
[C01BD01, amiodarone, The serum concentration of Afatinib can be increased when it is combined with Amiodarone.]
[N02AA01, morphine, The serum concentration of Morphine can be increased when it is combined with Afatinib.]
[B02BX05, eltrombopag, Eltrombopag may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be increased when it is combined with Afatinib.]
[G04CA04, silodosin, The excretion of Silodosin can be decreased when combined with Afatinib.]
[G03XC01, raloxifene, Afatinib may decrease the excretion rate of Raloxifene which could result in a higher serum level.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Afatinib.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[M04AA03, febuxostat, The excretion of Afatinib can be decreased when combined with Febuxostat.]
[J01XE01, nitrofurantoin, Afatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N06AA10, nortriptyline, The serum concentration of Nortriptyline can be increased when it is combined with Afatinib.]
[A16AX07, sapropterin, The serum concentration of Afatinib can be increased when it is combined with Sapropterin.]
[A02BC01, omeprazole, Omeprazole may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[C08CX01, mibefradil, The serum concentration of Afatinib can be increased when it is combined with Mibefradil.]
[J05AE01, saquinavir, The serum concentration of Afatinib can be increased when it is combined with Saquinavir.]
[J05AE03, ritonavir, The serum concentration of Afatinib can be increased when it is combined with Ritonavir.]
[V03AB21, potassium iodide, The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Afatinib.]
[C10AA08, pitavastatin, Afatinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[C02CA01, prazosin, Afatinib may decrease the excretion rate of Prazosin which could result in a higher serum level.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Prilocaine.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Procaine.]
[G03DA04, progesterone, Progesterone may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[C01BC03, propafenone, The serum concentration of Afatinib can be increased when it is combined with Propafenone.]
[R06AX26, fexofenadine, The serum concentration of Fexofenadine can be increased when it is combined with Afatinib.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be increased when it is combined with Afatinib.]
[H03BA02, propylthiouracil, The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Afatinib.]
[C01BA01, quinidine, The serum concentration of Afatinib can be increased when it is combined with Quinidine.]
[P01BC01, quinine, The serum concentration of Afatinib can be increased when it is combined with Quinine.]
[C02AA02, reserpine, The serum concentration of Afatinib can be increased when it is combined with Reserpine.]
[J04AB02, rifampin, The serum concentration of Afatinib can be decreased when it is combined with Rifampicin.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[L01CD04, cabazitaxel, The serum concentration of Cabazitaxel can be increased when it is combined with Afatinib.]
[L01FD03, ado-trastuzumab emtansine, The serum concentration of Trastuzumab emtansine can be increased when it is combined with Afatinib.]
